Abstract
#Colorectal cancer (CRC) is the third most common malignancy worldwide,
with an estimated one million new cases and a half million deaths each
year. Screening for CRC allows early stage diagnosis of the #malignancy
and potentially reduces disease mortality. The convenient and
inexpensive #fecal occult blood test (FOBT) screening test has low
sensitivity and requires dietary restriction, which impedes compliance
and use. Although #colonoscopy. Considered as the golden standard for the
screening for this cancer, the invasive nature, abdominal pain and high
cost have hampered worldwide application of this procedure. A
noninvasive sensitive screen for colon cancer (CC) requiring no dietary
restriction is a more convenient test. CC is more abundant in the USA
than rectal cancer (RC). The discovery of small noncoding protein
sequences, 17-27 #nucleotides long RNAs (such as microRNAs), has opened
new opportunities for a non-invasive test for early diagnosis of many
cancers.#MiRNA functions seem to regulate development and apoptosis, and specific
miRNAs are critical in #oncogenesis, effective in classifying solid and
liquid tumors, and serve as oncogenes or suppressor genes. MiRNA genes
are frequently located at #fragile sites, as well as minimal regions of
loss of #heterozygosity, or amplification of common break-point regions,
suggesting their involvement in carcinogenesis.
For more articles on BJSTR Journal please click on https://biomedres.us/
For more Biotechnology Articles on BJSTR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.